February 9, 2022 -- Capillary electrophoresis (CE), which enables Sanger sequencing and fragment analysis, is an important tool for improving clinical research and advancing scientific discovery. To further enable customers' cutting-edge research in areas such as gene editing and infectious disease, Thermo Fisher Scientific has introduced the new Applied Biosystems SeqStudio Flex Series Genetic Analyzer.
The Applied Biosystems SeqStudio Flex Series Genetic Analyzer. Image courtesy of Thermo Fisher.
The Flex Series analyzer delivers high-quality Sanger sequencing and fragment analysis data. Building on Applied Biosystems technology, the new midthroughput genetic analyzer introduces design and technological advancements for enhanced flexibility, usability, and connectivity. The instrument has increased plate capacity and may be loaded at any time without canceling or waiting for a run to complete, improving sample throughput, walk-away capacity, and scheduling flexibility, Thermo Fisher said.
In addition, the system's advanced Wi-Fi connectivity enables users to remotely set up and monitor runs, as well as to facilitate streamlined data transfer, analysis, and scientific collaboration. The SeqStudio Flex Series Genetic Analyzer is also the first CE-based instrument with remote servicing capabilities for faster issue resolution.
Copyright © 2022 scienceboard.net